Viral Prototypes for Pandemic Preparedness: The Road Ahead.

Area of Science:

• Virology
• Immunology
• Vaccinology

Background:

• The COVID-19 pandemic highlighted the success of rapid vaccine and monoclonal antibody (mAb) deployment, validating the prototype pathogen approach.
• Decades of research on coronavirus immunity and antigen characterization enabled a generalizable vaccine strategy for multiple coronaviruses.
• The field is less prepared for other virus families with pandemic potential.

Purpose of the Study:

• To identify research gaps and accelerate the development of vaccines and mAbs for future pandemic threats.
• To establish generalizable vaccine and mAb strategies applicable across different virus families.
• To enhance global preparedness against novel viral outbreaks.

Main Methods:

• Review and synthesis of research presented in the special issue.
• Identification of critical research areas for prototype pathogen preparedness.
• Analysis of interdisciplinary and cross-family research needs.

Main Results:

• The success with coronaviruses serves as a proof of concept for the prototype pathogen strategy.
• Significant research gaps exist for other virus families, hindering rapid response.
• A coordinated, multidisciplinary approach is essential for effective pandemic preparedness.

Conclusions:

• The prototype pathogen approach is a viable strategy for rapid response to novel viruses.
• Addressing identified research gaps is crucial for developing broadly applicable vaccines and mAbs.
• Enhanced collaboration across different virus research fields is necessary to bolster global health security.